Apsen and Lallemand Health Solutions launched a probiotic formulation for the brain-gut axis for the Brazilian market.
Image courtesy of Aspen
Apsen (São Paulo, Brazil) and Lallemand Health Solutions (Mirabel, Canada) launched a probiotic formulation for the brain-gut axis for the Brazilian market. The formulation is sold as two finished products called Probid and Probians, both of which carry approved health claims by the Brazilian Health Authorities, ANVISA. It has five clinical studies and several pre-clinical studies that highlight eight mechanisms of action on the brain-gut axis. The modes of action for this formula have been documented by nine mechanistic studies and five human studies on the brain-gut axis.
Probid and Probians contain Lactobacillus helveticus Rosell-52 and Bifidobacterium longum Rosell-175, the combination of which is specifically designed to support mood, and reduce stress. They are approved by the Brazilian regulatory agency for the following claims:
“We are proud to be the first in Brazil to launch a specific probiotic formulation, based on two strains known for their proven effects on stress level and mood balance,” said Kleber Vargas, technical and business development vice-president at Apsen, in a press release. “Apsen invested in research to provide this evolution to the Brazilian market, with an innovative product with a full array of health benefits.”
Polyphenols: The next generation of prebiotics is ready for liftoff
April 21st 2025Explore the prebiotic health benefits of polyphenols and the positive impact they may have on digestive and immune health. Polyphenols, such as those found in European black elderberry, may be an ideal solution for manufacturers trying to break into the digestive health space.